Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |